Literature DB >> 35895334

Clinical Utility of Combined Whole-cell Antigen and Recombinant Hemolysis Co-regulated Protein 1-Enzyme-linked Immunosorbent Assays Reveals Underdiagnosed Cases of Melioidosis in Vietnam.

Quyen T L Tran1, Ha V Nguyen1, Huyen T Pham2, Tuan V Mai3, Quyen H M Nguyen1, Dzung V Le2, Linh N H Bui1, Lan T H Hoang3, Trung Q Hoang2, Trung T Trinh1.   

Abstract

Melioidosis is a fatal infectious disease in the tropics and subtropics. Currently, bacterial culture is the gold standard for diagnosis of the disease, but its sensitivity is relatively low. In this study, we evaluated four ELISAs using sera collected from culture-confirmed cases of melioidosis (n = 63), cases with other bacterial infections (n = 62), and healthy donors (n = 60). Antigens used for ELISAs were the whole-cell (WC) antigens and recombinant proteins of hemolysis co-regulated protein 1 (Hcp1), GroEL1, and alkyl hydroperoxide reductase subunit C (AhpC). Using the cutoff values for optical density at 490 nm defined at a specificity of > 95%, the sensitivity of the WC, Hcp1, GroEL1, and AhpC ELISAs was 93.7%, 87.3%, 61.9%, and 57.1%, respectively. The combined WC/Hcp1 ELISA showed the greatest sensitivity and specificity of 98.4% and 95.1%, respectively. Of 511 and 500 sera collected from clinically suspected febrile patients admitted to the General Hospital of Ha Tinh Province and the Hue Central Hospital, respectively, combined WC/Hcp1 ELISAs showed 52 (10.2%) and 41 (8.2%) patients positive for melioidosis, respectively. The assay detected 14 of 14 (100%) and 21 of 23 (91.3%) culture-confirmed cases of melioidosis at Ha Tinh and Hue, respectively. A follow-up study of 38 patients positive for melioidosis by combined WC/Hcp1 ELISAs but negative for Burkholderia pseudomallei by culture method or not assigned to examine for bacterial culture resulted in 2 (5.3%) culture-reconfirmed patients with melioidosis, 9 (23.7%) deaths, 17 (44.7%) unhealthy patients, and 10 (26.3%) healthy persons. Combined WC/Hcp1 ELISA was a reliable serological method to detect underdiagnosed cases of melioidosis. Further investigations are needed to estimate the true sensitivity and specificity of the assay and the true number of cases of melioidosis.

Entities:  

Year:  2022        PMID: 35895334      PMCID: PMC9490659          DOI: 10.4269/ajtmh.21-1143

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  36 in total

1.  Development of antibodies to Burkholderia pseudomallei during childhood in melioidosis-endemic northeast Thailand.

Authors:  Vanaporn Wuthiekanun; Wirongrong Chierakul; Sayan Langa; Wipada Chaowagul; Chanathip Panpitpat; Penchan Saipan; Thaksinaporn Thoujaikong; Nicholas P Day; Sharon J Peacock
Journal:  Am J Trop Med Hyg       Date:  2006-06       Impact factor: 2.345

2.  Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis.

Authors:  Ella M Meumann; Ryan T Novak; Daniel Gal; Mirjam E Kaestli; Mark Mayo; Joshua P Hanson; Emma Spencer; Mindy B Glass; Jay E Gee; Patricia P Wilkins; Bart J Currie
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Quantitation of B. Pseudomallei in clinical samples.

Authors:  Vanaporn Wuthiekanun; Direk Limmathurotsakul; Gumphol Wongsuvan; Wirongrong Chierakul; Nittaya Teerawattanasook; Prapit Teparrukkul; Nicholas P Day; Sharon J Peacock
Journal:  Am J Trop Med Hyg       Date:  2007-11       Impact factor: 2.345

4.  Enzyme-linked immunosorbent assay for the diagnosis of clinical and subclinical melioidosis.

Authors:  L R Ashdown; R W Johnson; J M Koehler; C A Cooney
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

5.  Evaluation of a latex agglutination assay for the identification of Burkholderia pseudomallei and Burkholderia mallei.

Authors:  Brea D Duval; Mindy G Elrod; Jay E Gee; Narisara Chantratita; Sarunporn Tandhavanant; Direk Limmathurotsakul; Alex R Hoffmaster
Journal:  Am J Trop Med Hyg       Date:  2014-04-07       Impact factor: 2.345

6.  Melioidosis diagnostic workshop, 2013.

Authors:  Alex R Hoffmaster; David AuCoin; Prasith Baccam; Henry C Baggett; Rob Baird; Saithip Bhengsri; David D Blaney; Paul J Brett; Timothy J G Brooks; Katherine A Brown; Narisara Chantratita; Allen C Cheng; David A B Dance; Saskia Decuypere; Dawn Defenbaugh; Jay E Gee; Raymond Houghton; Possawat Jorakate; Ganjana Lertmemongkolchai; Direk Limmathurotsakul; Toby L Merlin; Chiranjay Mukhopadhyay; Robert Norton; Sharon J Peacock; Dionne B Rolim; Andrew J Simpson; Ivo Steinmetz; Robyn A Stoddard; Martha M Stokes; David Sue; Apichai Tuanyok; Toni Whistler; Vanaporn Wuthiekanun; Henry T Walke
Journal:  Emerg Infect Dis       Date:  2015-02       Impact factor: 6.883

7.  Development of Rapid Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Burkholderia pseudomallei.

Authors:  Vichaya Suttisunhakul; Vanaporn Wuthiekanun; Paul J Brett; Srisin Khusmith; Nicholas P J Day; Mary N Burtnick; Direk Limmathurotsakul; Narisara Chantratita
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

8.  Less is more: Burkholderia pseudomallei and chronic melioidosis.

Authors:  Tannistha Nandi; Patrick Tan
Journal:  mBio       Date:  2013-09-24       Impact factor: 7.867

9.  Burkholderia pseudomallei antibodies in children, Cambodia.

Authors:  Vanaporn Wuthiekanun; Ngoun Pheaktra; Hor Putchhat; Lina Sin; Bun Sen; Varun Kumar; Sayan Langla; Sharon J Peacock; Nicholas P Day
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

10.  Melioidosis mimicking primary lung malignancy with superior vena cava obstruction.

Authors:  Malcolm Wilson; Simon Smith; James Brown; Josh Hanson
Journal:  IDCases       Date:  2016-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.